Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a frequent cause of cancer-related death; therefore, more effective anticancer therapies for the treatment of HCC are needed. Histone deacetylase (HDAC) inhibitors serve as promising anticancer drugs because they can induce cell growth arrest and apoptosis. We previ...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mei-Chuan, Huang, Hui-Hsuan, Lai, Chin-Yu, Lin, Yi-Jyun, Liou, Jing-Ping, Lai, Mei-Jung, Li, Yu-Hsuan, Teng, Che-Ming, Yang, Chia-Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808007/
https://www.ncbi.nlm.nih.gov/pubmed/26587975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808007/
https://www.ncbi.nlm.nih.gov/pubmed/26587975

Ejemplares similares